ALVAL fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Valbiotis SA engages in the products and candidate drugs designed to prevent metabolic diseases. The company was founded on December 2, 2014 and is headquartered in Perigny, France.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
ALVAL has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company